Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020
Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
ScriptPro and TCGRx Integrate Pharmacy Automation Technologies
GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois
CVS Caremark Corporation To Hold Second Quarter 2014 Conference Call
The Hepatitis C virus is the main cause of liver transplant in the world
Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com
Acsis Addresses Questions on the Modern Supply Chain
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
AbbVie Reports Second-Quarter 2014 Financial Results
CPhI South America 2014 Launches with Generics Showing Huge Growth
Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer
AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
iMD Companies Inc., Receives $500,000.00 Short Term Funding Commitment from Private Investment Group
Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
IGI Laboratories Announces Second Quarter 2014 Results
IGI Laboratories, Inc. Announces Change To Its Board Of Directors
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
Amgen Announces Webcast of 2014 Second Quarter Financial Results
Alimera Sciences To Release Second Quarter 2014 Results
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States
Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%
CorMedix, Inc. Granted Extension of NYSE-MKT Listing
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
Talyst Exhibits at the National Association of State Veterans Homes Summer Conference
Study Finds Pycnogenol® Effective In Improving Inner Ear Circulation With Relief Of Symptoms Of Meniere's Disease Including Tinnitus
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma
Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15
Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs
Questcor Reports Record Second Quarter Financial Results
Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019
North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020
'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership
Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.
Lilly Reports Second-Quarter 2014 Results
OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014

< Prev Next >
PR Newswire - United Business Media